Collaborating in more than 150 markets.
By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com.
These sections or websites are governed by their own Legal and Privacy Policies.
Global
Asia Pacific
Europe, Middle East & Africa (EMEA)
Latin America
Home › Janssen Submits Esketamine Nasal Spray New Drug Application to U.S. FDA for Treatment - Resistant Depression
Janssen Submits Esketamine Nasal Spray New Drug Application to U.S. FDA for Treatment - Resistant Depression
Sep 04, 2018
TITUSVILLE, NJ